Search results
Precigen Reports First Quarter 2024 Financial Results and Business Updates
WRBL Columbus· 3 days ago...presented at the 2024 ASCO Annual Meeting as a late-breaking oral presentation on June 3rd – – Company to host a conference call on June 3rd following the PRGN-2012 ASCO presentation to discuss in detail the pivotal study results and provide business updates – – PRGN-2012 rolling BLA submission,...
New virus variants threaten a summer Covid-19 wave, but experts say the risk remains uncertain
CNN via Yahoo News· 5 hours agoCovid-19 levels are about the lowest they’ve ever been in the United States, but another new crop of...
Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update
Hi-Desert Star· 3 days agoTalphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings ...
Ainos to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's...
Digital Journal· 2 days agoSAN DIEGO, CA / ACCESSWIRE / May 15, 2024 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on the development of novel point-of-care testing ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 1 day agoCompleted acquisition of Trawsfynydd and concurrent $14 million Capital Raise Excellent pipeline progress, led by candidates for COVID 19, influenza, and oncology programs Poised to initiate Phase 2 studies in H2 2024 for our influenza candidate
France to name Dallas publisher a Knight of the Order of Arts and Letters
Dallas Morning News· 4 hours agoMonday, Evans will be thanked for his efforts spreading French literature by officially becoming a...
Internet applauds how divorced couple make co-parenting work: "Wholesome"
Newsweek· 2 days agoThere has been a significant increase in the number of divorced couples co-parenting their kids. A...
Earnings call: Atea Pharmaceuticals reports progress in COVID-19 trial By Investing.com
Investing.com· 2 days agoAtea Pharmaceuticals, a biopharmaceutical company focused on developing therapeutics for viral...
AI can make it hard to separate truth from fiction. Here’s how to tell the difference.
The Des Moines Register via Yahoo News· 6 days agoFor better health outcomes, we need to connect more Iowa...impersonating the school’s principal. The clip was posted on Instagram, went viral, and before the truth could come ...
Medication for deadly cat virus soon to be available in US: ‘Huge triumph’
NY Post via Yahoo News· 2 days agoMany cat owners are rejoicing at the news that a drug used to treat an otherwise fatal illness for...